Cargando…
The Genomics of Neonatal Abstinence Syndrome
Significant variability has been observed in the development and severity of neonatal abstinence syndrome (NAS) among neonates exposed to prenatal opioids. Since maternal opioid dose does not appear to correlate directly with neonatal outcome, maternal, placental, and fetal genomic variants may play...
Autores principales: | Cole, F. Sessions, Wegner, Daniel J., Davis, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572235/ https://www.ncbi.nlm.nih.gov/pubmed/28879171 http://dx.doi.org/10.3389/fped.2017.00176 |
Ejemplares similares
-
Editorial: The neurology and neurobiology of neonatal abstinence syndrome
por: Clemens, Kelly J., et al.
Publicado: (2023) -
Neonatal Abstinence Syndrome: Twins Case Series
por: Pandey, Rajesh, et al.
Publicado: (2017) -
Feeding Modalities and the Onset of the Neonatal Abstinence Syndrome
por: Liu, Anthony, et al.
Publicado: (2015) -
EEG Findings in Infants With Neonatal Abstinence Syndrome Presenting With Clinical Seizures
por: Palla, Murali Reddy, et al.
Publicado: (2019) -
Neonatal Abstinence Syndrome: An Insight Over Impact of Maternal Substance Use
por: Dumbhare, Omkar, et al.
Publicado: (2023)